Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting.

MLA

Maggi, Paolo, et al. “Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting.” Viruses, vol. 15, no. 7, July 2023. EBSCOhost, https://doi.org/10.3390/v15071612.

APA

Maggi, P., Ricci, E. D., Martinelli, C. V., De Socio, G. V., Squillace, N., Molteni, C., Masiello, A., Orofino, G., Menzaghi, B., Bellagamba, R., Vichi, F., Celesia, B. M., Madeddu, G., Pellicanò, G. F., Carleo, M. A., Cascio, A., Parisini, A., Taramasso, L., Valsecchi, L., … Bonfanti, P. (2023). Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting. Viruses, 15(7). https://doi.org/10.3390/v15071612

Chicago

Maggi, Paolo, Elena Delfina Ricci, Canio Vito Martinelli, Giuseppe Vittorio De Socio, Nicola Squillace, Chiara Molteni, Addolorata Masiello, et al. 2023. “Lipids and Transaminase in Antiretroviral-Treatment-Experienced People Living with HIV, Switching to a Doravirine-Based vs. a Rilpivirine-Based Regimen: Data from a Real-Life Setting.” Viruses 15 (7). doi:10.3390/v15071612.